C. R. Bard has acquired 23 companies of its own. A total of 4 acquisitions came from private equity firms. It has also divested 1 asset.
C. R. Bard’s largest acquisition to date was in 2013, when it acquired Rochester Medical for $262M. It’s largest disclosed sale occurred in 2013, when it sold Bard EP to Boston Scientific for $275M. C. R. Bard has acquired in 10 different US states, and 2 countries. The Company’s most targeted sectors include medical products (78%) and healthcare services (19%).
Join Mergr and gain access to C. R. Bard’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.
M&A Total Activity23
- M&A Buy Activity22
- M&A Sell Activity1
- Total Sectors Invested 3
- Total Countries Invested 2
- M&A Buy/Sell Connections 5